Orgenesis (OTC:ORGS) (fka Business Outsourcing Services)

A molecular and cellular approach to treating diabetes, in which autologous liver cells are converted into functional insulin-producing cells .

Get a Demo and See the Full Profile

Get a demo today to see profiles of Orgenesis (OTC:ORGS) (fka Business Outsourcing Services) plus 6035 other startups.

Learn More About Orgenesis (OTC:ORGS) (fka Business Outsourcing Services)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More